35.73 0.00(0.00%) Date: Aug 22, 8:24AM EDT

Credit Suisse Initiates Sarepta Therapeutics Inc (SRPT) With Outperform; Shares Shoot Up

Credit Suisse analysts believe Exondys 51 may only be the beginning for Sarepta

Sarepta Therapeutics Inc (SRPT): Wedbush Expects Rapid Uptake Of DMD Drug On Launch

Wedbush analyst believes Exondys 51 will not face concerning reimbursement challenges